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Abstract
Aluminium is biologically reactive and its ability to potentiate the immune response has driven its inclusion in both veterinary 
and human vaccines. Consequently, the need for unequivocal visualisation of aluminium in vivo has created a focused research 
effort to establish fluorescent molecular probes for this purpose. The most commonly used direct fluorescent labels for the 
detection of aluminium are morin (2′,3,4′,5,7-pentahydroxyflavone) and lumogallion [4-chloro-3-(2,4-dihydroxyphenylazo)-
2-hydroxybenzene-1-sulphonic acid]. While the former has gained popularity in the detection of aluminium in plants and 
predominantly within root tips, the latter boasts greater sensitivity and selectivity for the detection of aluminium in human 
cells and tissues. Herein, we have developed a simplified morin staining protocol using the autofluorescence quenching 
agent, Sudan Black B. This modified protocol improves tissue morphology and increases analytical sensitivity, which allows 
intracellular aluminium to be detected in monocytes and when co-localised with senile plaques in human brain tissue of 
donors diagnosed with familial Alzheimer’s disease. Overall, our results demonstrate a simple approach to minimise false 
positives in the use of morin to unequivocally detect aluminium in vivo.
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Introduction
Aluminium is the third most abundant element and the most 
abundant metal in the Earth’s crust. In spite of its ubiquity, 
however, aluminium is non-essential to life and its ability to 
participate in myriad biochemical processes is known to 
exert toxicity in vivo (Exley 2016). The biologically reactive 
form of aluminium is its free solvated trivalent metal cation, 
Al3+
(aq)
 (Exley and Mold 2015). The increased liberation of the 
free metal cation in soils by acid rain has shown to be of 
detriment to the root apical meristem of young seedlings, in 
which the inhibition of cell elongation and subsequent cell 
death has been demonstrated (Yamamoto 2019).
The cellular uptake and transport of aluminium in humans 
are dictated by physicochemical properties including the 
molecular weight, size and charge of the aluminium spe-
cies. For example, while low molecular weight neutral 
complexes of aluminium are predicted to traverse cells via 
passive transport and enter via passive diffusion (Exley and 
Mold 2015), particulate forms of the metal ion are trans-
ported intracellularly via non-receptor mediated endocytosis 
(Mold et al. 2014). The latter has relevance for the cellular 
uptake of aluminium adjuvants that are included in human 
vaccinations to potentiate and shape the immune response 
(Reed et al. 2013; Shardlow et al. 2018). Therefore, under-
standing the mechanisms driving the cellular uptake and fate 
of aluminium are crucial in the development of both new and 
existing vaccines (Shardlow et al. 2018).
The f luorophore, lumogallion [4-chloro-3-(2,4-
dihydroxyphenylazo)-2-hydroxybenzene-1-sulphonic acid] 
has demonstrated the unequivocal identification of alumin-
ium in cellular models of vaccination (Mold et al. 2016, 
2018a), human sperm cells (Klein et al. 2014) and in inocu-
lated ovine (Asin et al. 2019) and murine tissues (Kashiwagi 
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et al. 2014). Lumogallion has also allowed for the identifica-
tion of aluminium in animal models in which the metal was 
identified in the reproductive tissues and brains of Wistar 
rats exposed to aluminium in their diet (Martinez et al. 2017, 
2019). Aluminium has also been visualised using lumogal-
lion in the brains of donors diagnosed with sporadic and 
familial Alzheimer’s disease (fAD) (Mirza et al. 2017; Mold 
et al. 2019a), autism spectrum disorder (ASD) (Mold et al. 
2018b), multiple sclerosis (MS) (Mold et al. 2018c) and epi-
lepsy (Mold et al. 2019b). Therein, the spatial distribution of 
aluminium across complex neurological disorders has been 
visualised in the human brain, allowing for the fate of the 
metal ion to be elucidated.
Lumogallion acts as a planar tridentate ligand for alumin-
ium coordinating to the metal ion through its two phenolic 
oxygen ions and the azo group forming aromatic linkages 
bound through a complex ring structure (Wu et al. 1995). 
Upon excitation of the fluorophore (500 nm) an orange fluo-
rescence emission (590 nm) is produced. Other physiologi-
cally relevant divalent and trivalent metal cations includ-
ing Ca(II), Cu(II), Mg(II), Zn(II) and Fe(III) (Ren et al. 
2001), fail to yield fluorescence in the presence of lumogal-
lion even when prepared as surrogate tissues (Mirza et al. 
2016). While competitive equilibria exist between Fe(III) 
and Al(III), when lumogallion binds to Fe(III), the bond 
produced is non-fluorescent (Hydes and Liss 1976). As 
such, high concentrations of Fe(III) have only previously 
been observed to produce a weaker fluorescence emission 
for Al(III), that is likely explained by the occlusion of the 
lumogallion binding site when coordinated to Fe(III) (Hydes 
and Liss 1976).
While a growing body of evidence demonstrates lumogal-
lion as a sensitive and selective fluorescent molecular probe 
for the visualisation of aluminium in both cells and tissues, 
morin (2′,3,4′,5,7-pentahydroxyflavone) continues to pre-
dominate studies of aluminium distribution in vivo (Eidi 
et al. 2015; Chkheidze et al. 2017; Dominguez-Renedo et al. 
2019). Unlike lumogallion that coordinates 1:1 with alu-
minium with high selectivity, morin binds to divalent metal 
cations including calcium and magnesium, yielding a green 
fluorescence emission (515 nm) upon excitation at 420 nm, 
as is observed upon its 3:1 coordination to aluminium 
(Browne et al. 1990). Such false positives are not encoun-
tered using lumogallion (Hydes and Liss 1976; Ren et al. 
2001; Mirza et al. 2016). Autofluorescence describes the 
observation of intrinsic fluorescence in the absence of any 
added dye or fluorophore. Autofluorescence of human cells 
and tissues is frequently observed to produce a green fluores-
cence emission of the non-stained tissue (Klein et al. 2014; 
Mold et al. 2014; Asin et al. 2019). In contrast to the orange 
fluorescence signal of lumogallion, morin produces a green 
fluorescence emission upon binding to aluminium (Browne 
et al. 1990). Therefore, establishing an autofluorescence 
background is of critical importance when determining the 
contribution of the fluorophore, to the overall fluorescence 
signal observed. Such comparisons are rarely demonstrated 
in studies using morin for the visualisation of aluminium 
(Chkheidze et al. 2017).
Herein, we have optimised an improved method for the 
unequivocal imaging of aluminium in human cells and 
human brain tissue using morin. Through staining opti-
misation and selective quenching of background autofluo-
rescence, we unequivocally demonstrate the presence of 
aluminium using morin, as confirmed by complementary 
lumogallion staining. Our results highlight notable meth-
odological improvements for the detection of aluminium 
in vivo utilising morin made achievable by increasing the 
signal-to-noise ratio of the fluorophore. Taken collectively, 
our results support autofluorescence quenching as a simple 
and adaptable approach in visualising directly labelled fluo-
rescent moieties, above background.
Materials and methods
T helper 1 cell culture
All chemicals were obtained from Sigma-Aldrich (Poole, 
UK) unless otherwise stated. T helper 1 (THP-1) cells were 
obtained from ATCC (TIB-202, LGC Standards, London, 
UK) and cultured in complete R10 medium containing 
RPMI 1640 supplemented with GlutaMAX™ contain-
ing 25 mM HEPES and 10% v/v heat-inactivated foetal 
bovine serum (FBS, Certified US Origin, both from Fisher 
Scientific, Invitrogen, Loughborough, UK). Gentamicin 
was added at a final concentration of 100 μg/mL from a 
cell culture certified 10 mg/mL stock solution in ultrapure 
water, to inhibit microbial growth. Growing cultures were 
established in canted Tissue Culture (TC) treated and vented 
T25 cell culture flasks to approximately 1 × 106 cells/mL, 
prior to sub-culturing into T75 flasks (both from VWR, 
 Corning®, Leicestershire, UK). Cells were cultured at 37 °C 
in a humidified atmosphere containing 5%  CO2 in a dedi-
cated cell incubator. A Neubauer improved haemocytometer 
(VWR Marienfeld, Stuttgart, Germany) was used to deter-
mine cell density. Cell viability was confirmed by use of the 
Trypan blue exclusion test in which viable cells excluded the 
dye from their cytoplasm.
For the assessment of aluminium-based adjuvant (ABA) 
uptake, THP-1 cells were co-cultured in the absence or 
presence of an aluminium oxyhydroxide-based adjuvant, 
 Alhydrogel® (2%) (Brenntag Biosector, Frederikssund, 
Denmark). Native cells were cultured in the presence of 
R10 medium only.  Alhydrogel® was first diluted to 1 mg/
mL in a sterile (0.22 μm filtered and autoclaved) 0.9% w/v 
sodium chloride simulated vaccine diluent, prior to dilution 
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into R10 medium. Cells were plated 1:1 with 100 μL of R10 
medium only or with the diluted ABA at a final concentra-
tion of 50 μg/mL in 96 well plates (TC treated, VWR, Corn-
ing  Costar®, Leicestershire, UK) and incubated for 24 h at 
37 °C (5%  CO2).
Human brain tissue
Human brain tissue was supplied following ethical approval 
(08/MRE09/38 + 5) from the Medical Research Council 
(MRC) London Neurodegenerative Diseases Brain Bank at 
Kings College London, UK. Samples of cortex from three 
donors with familial Alzheimer’s disease (fAD) were pro-
vided as paraffin-embedded tissue blocks mounted on Tis-
sue-Tek embedding cassettes (VWR,  Sakura® Finetek, Har-
risburg, PA, US). Donor A1 is a male donor, aged 47 with 
Braak/Brain Net Europe (BNE) stage VI pathology (BBN-
ID: BBN_16320). Donor A5 is a male donor aged 60 with 
a Braak stage of at least IV (BBN_13887). Donor A8 is a 
female donor aged 65 with a presenilin 1 mutation (E280G) 
and a Braak stage of VI with Lewy bodies (BBN_13813). 
Early-onset fAD was classified in all donors as described by 
Mirza and co-workers (Mirza et al. 2017).
Paraffin embedding of agar‑cell blocks
THP-1 cells co-cultured in the absence or presence of 
 Alhydrogel® were pooled across respective cell treatments 
and pelleted via centrifugation at 800g for 10 min, as previ-
ously described (Mold et al. 2014). Briefly, cells were re-
suspended in 4% w/v paraformaldehyde in 25 mM PIPES, 
pH 7.4 for 20 min. Fixed cell treatments were washed three 
times with a 50 mM PIPES buffer adjusted to pH 7.4 with 
sodium hydroxide pearls, of which 30 μL 5% w/v molten 
agar was added to the final pellets. HPLC-grade ethanol 
was used in all procedures whenever required. Agar-cell 
blocks were gradually dehydrated through an ethanol gra-
dient of 30, 50, 70, 90, 98 and 100% v/v for 20 min, fol-
lowed by incubation in fresh 100% v/v ethanol, for a further 
20 min. Blocks were cleared via transfer into Histo-Clear™ 
(National Diagnostics, Nottingham, UK) for 40 min, with 
one change of fresh Histo-Clear™ halfway through. Cleared 
agar-cell blocks were infiltrated in molten paraffin wax at 
60 °C for 40 min and rapidly cast onto Tissue-Tek embed-
ding cassettes (VWR,  Sakura® Finetek, Harrisburg, PA, US) 
on ice, followed by overnight incubation at 4 °C to set the 
final paraffin-embedded blocks.
Microtomy
Paraffin-embedded brain tissue and paraffin-embedded agar-
cell blocks were cooled on wet ice for 3 h to increase tissue 
hardness, thereby minimising sample imperfections upon 
sectioning. All blocks were sectioned by use of a Leica 
(Wetzlar, Germany) RM2025 rotary microtome using Leica 
Surgipath DB80LX low profile blades. Ribbons of serially 
cut sections (i.e. sectioned one after the other) were prepared 
at a thickness of 5 μm for brain tissue and 2 μm for THP-1 
cells. All paraffin-embedded sections were floated out onto 
ultrapure water (conductivity < 0.067 μS/cm) at 45 °C for 
30 s, allowing for gentle tissue expansion. Sections for brain 
tissue and THP-1 cells were caught on numbered electrostat-
ically charged  SuperFrost® Plus glass slides (Thermo Fisher 
Scientific, Loughborough, UK), respectively. Sections were 
subsequently stored vertically and allowed to dry at ambient 
temperature overnight. For paraffin-embedded brain tissue 
only, sections were incubated in a paraffin slide heater at 
60 °C for 20 min to remove excess paraffin and were allowed 
to cool to ambient temperature, prior to staining.
Deparaffinisation and rehydration procedures
Directly adjacent and numbered serial THP-1 cell or brain 
tissue sections were prepared as separate sets, to allow for 
their analysis via morin, lumogallion or autofluorescence 
quenching, respectively. Solvents for deparaffinisation and 
rehydration of paraffin-embedded sections were prepared at 
a final volume of 250 mL in glass staining dishes. All brain 
tissue and THP-1 cell sections were deparaffinised with gen-
tle agitation via immersion into Histo-Clear™ for 3 min. To 
ensure that any residual paraffin was removed, sections were 
immersed in fresh Histo-Clear™ for a further minute. Sec-
tions were gradually rehydrated through an ethanol gradient 
via transfer for 1 min into 100, 95, 70, 50 and 30% v/v etha-
nol. Sections were finally immersed in ultrapure water and 
agitated continuously for 35 s. A PAP pen was used to create 
a hydrophobic barrier around rehydrated sections, allowing 
for low reagent volumes (200 μL) to be used via staining 
in humidity chambers. Sections were subsequently stained 
and mounted according to the following staining procedures.
Lumogallion staining
Lumogallion [4-chloro-3-(2,4-dihydroxyphenylazo)-2-hy-
droxybenzene-1-sulphonic acid] (Tokyo Chemical Industry, 
Oxford, UK) was prepared at 1 mM via dilution into 0.22 μm 
filtered 50 mM PIPES buffer, pH 7.4. Deparaffinised and 
rehydrated THP-1 cell or brain serial sections were stained 
away from light for 45 min at ambient temperature with 
either lumogallion or 50 mM PIPES buffer only, of which 
the latter acted as a control for autofluorescence. Following 
staining, sections were subsequently washed six times with 
200 μL aliquots of 50 mM PIPES buffer, prior to a 30 s 
rinse in ultrapure water. Mounting of stained sections was 
performed using glass coverslips using the aqueous mount-
ing medium Fluoromount™ for all brain tissue sections and 
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the aqueous mounting medium,  ProLong® Gold Antifade 
Reagent with 4′,6-diamidino-2-phenylindole, dihydrochlo-
ride (DAPI) (Life Technologies, Fisher Scientific, Lough-
borough, UK) for THP-1 cell sections. The latter was used 
to highlight THP-1 cell nuclei. All sections were incubated 
overnight at 4 °C away from light allowing for the respec-
tive polymers to harden, prior to analysis via fluorescence 
microscopy.
Sudan Black B as an autofluorescence quenching 
agent of lumogallion‑stained human brain tissue 
sections
Sudan Black B (SBB) was prepared as an autofluorescence 
quenching agent via dilution in 70% v/v ethanol and was 
centrifuged for 5 min at 8000g, immediately prior to use. 
Prior to mounting, lumogallion-stained brain tissue sec-
tions were post-incubated with 0.01 or 0.10% w/v SBB, 
washed six times with 200 μL aliquots of 70% v/v ethanol 
and rinsed for 30 s in ultrapure water. Sections were subse-
quently mounted using Fluoromount™ and were incubated 
overnight at 4 °C away from light, prior to analysis via fluo-
rescence microscopy.
Shaw’s morin staining
Conventional Shaw’s morin staining was performed as pre-
viously reported (Shaw and Petrik 2009) and is outlined in 
Table 1. Briefly, morin was prepared at 0.2% w/v in 85% 
v/v ethanol, containing 0.5% v/v acetic acid. Rehydrated 
THP-1 or human brain tissue sections were twice incubated 
in fresh solutions of 0.22 μm filtered phosphate buffered 
saline (PBS), pH 7.0, for 5 min. Sections were subsequently 
acidified in 1% v/v HCl for 10 min, followed by two 5 min 
washes in ultrapure water. Morin staining was performed in 
humidity chambers via the addition of 200 μL of the fluo-
rophore, of which sections were incubated for 10 min. Fol-
lowing staining, sections were twice rinsed via immersion 
in ultrapure for 5 min, sequentially dehydrated through 70, 
90 and 100% v/v ethanol and cleared with xylene (via full 
immersion in each solvent for approximately 30 s). Cleared 
and stained sections were immediately mounted using glass 
coverslips with the DPX-based mounting medium, Omni-
mount™ (National Diagnostics, Nottingham, UK). Stained 
and mounted sections were allowed to cure fully and were 
sealed with clear nail varnish, prior to analysis via fluores-
cence microscopy.
Optimised morin staining using Sudan Black B
A comparison of staining protocols for conventional Shaw’s 
morin staining (Shaw and Petrik 2009) versus an optimised 
morin staining protocol developed herein, is given in Table 1. 
Shaw’s morin solution omitting the addition of acetic acid 
was added to rehydrated tissue sections for 30 min in humid-
ity chambers. Following morin staining, tissue sections were 
washed six times with 200 μL aliquots of 85% v/v ethanol 
and rinsed in ultrapure water for 35 s. Tissue sections were 
subsequently incubated for 10 min in 0.3% w/v SBB in 70% 
v/v ethanol, washed six times with 200 μL aliquots of 70% v/v 
ethanol and rinsed for 30 s in ultrapure water (Table 1). THP-1 
cell sections prepared in this way were mounted with ProLong 
Gold antifade reagent with DAPI under glass coverslips (Life 
Technologies, Fisher Scientific, Loughborough, UK). Brain 
Table 1  A comparison between 
protocols and durations for 
Shaw’s morin staining and 
an optimised morin staining 
protocol for deparaffinised and 
rehydrated cell and brain tissue 
sections (Shaw and Petrik 2009)
Shaw’s morin staining Optimised morin staining
Steps Reagent Time Steps Reagent Time
1. PBS, pH 7.0 5 min 1. 0.2% w/v morin, 
85% v/v ethanol
30 min
2. PBS, pH 7.0 5 min 2. 85% v/v ethanol 30 s
3. 1% v/v HCl 10 min 3. Ultrapure water 35 s
4. Ultrapure water 5 min 4. 0.3% w/v Sudan 
Black B, 70% v/v 
ethanol
10 min
5. Ultrapure water 5 min 5. 70% v/v ethanol 30 s
6. 0.2% w/v morin, 85% v/v etha-
nol, 0.5% v/v acetic acid
10 min 6. Ultrapure water 30 s
7. Ultrapure water 5 min Total Time ~ 42 min
8. Ultrapure water 5 min
9. 70% v/v ethanol 30 s
10. 90% v/v ethanol 30 s
11. 100% v/v ethanol 30 s
12. Xylene 30 s
Total time ~ 52 min
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tissue sections were mounted with Fluoromount™ and all sec-




Non-specific staining of morin attributed to the binding of 
magnesium and calcium was minimised via pre-soaking rehy-
drated THP-1 cell sections in 250.0 mL of 0.22 μm filtered 
5 mM ethylenediaminetetraacetic acid  (Na2EDTA) for 10 min 
(Browne et al. 1990). Sections were subsequently washed in 
ultrapure water for 35 s, prior to staining in modified Shaw’s 
morin omitting the addition of acetic acid for the reduced dura-
tion of 10 min. Sections were subsequently rinsed for 30 s 
in 85% v/v followed by a 35 s rinse in ultrapure water, prior 
to mounting with ProLong Gold antifade reagent with DAPI 
(Life Technologies, Fisher Scientific, Loughborough, UK).
Fluorescence microscopy
Human brain and THP-1 cell sections were analysed using an 
Olympus BX50 fluorescence microscope equipped with a verti-
cal illuminator and BX-FLA reflected fluorescent light attach-
ment (mercury source). Fluorescence micrographs were obtained 
by use of a X 40 Plan-Fluorite objective or under a low autofluo-
rescence immersion oil (Olympus immersion oil, type-F) under 
a X 100 Plan-Fluorite objective (both from Olympus, South-
end-on-Sea, UK), respectively. Lumogallion (orange) and morin 
(green) fluorescence were visualised using a U-MNIB3 fluores-
cence filter cube (bandpass λex: 470–495 nm, dichromatic mirror: 
505 nm, longpass λem: 510 nm) and U-MWBV2 cube (bandpass 
λex: 400–440 nm, dichromatic mirror: 455 nm, longpass λem: 
475 nm), respectively. DAPI staining of cell nuclei (blue) was 
visualised by use of a U-MWU2 (bandpass λex: 330–385 nm, 
dichromatic mirror: 400 nm, longpass λem: 420 nm) filter cube. 
All filter cubes were purchased from Olympus (Southend-on-
Sea, UK). Light transmission and exposure values were fixed 
across treatment conditions and images captured using a Color-
View III CCD camera using the CellD software suite (Olympus, 
Soft Imaging Solutions, SiS, GmbH, Münster, Germany). Merg-
ing of bright-field and fluorescence channels was performed 
using Photoshop (Adobe Systems Inc., Palo Alto, CA, US).
Results
Post‑staining with Sudan Black B (SBB) aids 
in the visualisation of intracellular aluminium 
adjuvant in T helper 1 monocytes
Native T helper 1 (THP-1) cells cultured for 24 h in the 
absence (Fig. 1a), or presence (Fig. 1b) of 50 μg/mL of an 
aluminium oxyhydroxide-based  Alhydrogel® adjuvant and 
stained with 0.3% w/v Sudan Black B (SBB) only, produced 
no detectable morin fluorescence (U-MWBV2, longpass λem: 
475 nm). While SBB was found to quench cellular auto-
fluorescence, positive DAPI staining of post-SBB stained 
THP-1 cell nuclei remained readily detected by a blue fluo-
rescence emission, in all treatments (Fig. 1). Morin staining 
only in treatments containing native THP-1 cells (Fig. 1c) or 
those co-cultured with  Alhydrogel® (Fig. 1d), both revealed 
a uniform green fluorescence emission contained within 
cell cytosol. As such, while the latter cell treatments clearly 
depicted extracellular adjuvant (Fig. 1d), its internalisation 
versus native cells (Fig. 1c) was rendered indistinguishable.
Post-incubation of morin-stained native THP-1 cells 
with SBB, quenched autofluorescence as evidenced by a 
diminished fluorescence intensity within the cell cytoplasm 
(Fig. 1e). Interestingly, under identical staining conditions 
THP-1 cells co-cultured with 50 μg/mL  Alhydrogel® for 
24 h, revealed punctate intracellular fluorescence (Fig. 1f). 
Weak intracellular fluorescence was initially observed (see 
Supplementary Fig. 1) under illumination settings typically 
used for the visualisation of morin fluorescence (excitation: 
470–495 nm, dichromatic mirror: 505 nm, longpass emis-
sion: 510 nm). Illumination under an alternative morin filter 
cube increased the intensity of the intracellular fluorescence 
signal (U-MWBV2, excitation: 400–440 nm, dichromatic 
mirror: 455 nm, longpass emission: 475 nm) and was, there-
fore, used in all post-SBB staining experiments.
Therein morin-stained THP-1 cells post-labelled with 
SBB demonstrated intracellular particulates with an outer 
diameter of 0.97 ± 0.13 μm (mean ± SD, n = 30) that were 
found exclusively within the cytoplasm of THP-1 cells 
(Fig.  1f). Furthermore, extracellular fluorescence was 
quenched with minimal extracellular particulate material 
observed across THP-1 cell sections (Fig. 1f). Conventional 
Shaw’s morin staining of native THP-1 cells prepared in 
the absence of added adjuvant produced a yellow fluores-
cence emission in cell cytosol (see Supplementary Fig. 2). 
Similarly, cells co-cultured in the presence of 50 μg/mL 
 Alhydrogel® produced a similar yellow fluorescence emis-
sion, thereby hindering the detection of intracellular particu-
lates of the adjuvant. Such was not resolved even when cells 
were illuminated under the modified morin filter set, as used 
in the optimised SBB-staining experiments.
Metal chelation using ethylenediaminetetraacetic 
acid (EDTA) as a fluorescence quenching agent
Further attempts to reduce intrinsic cellular autofluores-
cence of morin-stained THP-1 cells were made via their 
pre-treatment using the hexadentate ligand, ethylenediami-
netetraacetic acid (EDTA). THP-1 cells co-cultured with 
50 μg/mL  Alhydrogel®, pre-treated with EDTA and stained 
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with morin revealed a green fluorescence emission contained 
within cell cytosol (Fig. 2a). Therein, punctate fluorescence 
was observed, however the identification of intracellular 
particulates was at times hindered owing to an intense fluo-
rescence emission masking intracellular adjuvant upon stain-
ing. Green fluorescence was also noted within the cytoplasm 
of native THP-1 cells stained in an identical manner, thereby 
accounting for their high fluorescence background (see Sup-
plementary Fig. 3).
Identical THP-1 cell treatments co-cultured with 50 μg/
mL  Alhydrogel® and stained with lumogallion revealed an 
intense intracellular punctate orange (single bandpass λem: 
570–610 nm) fluorescence emission (Fig. 2b). Therein, dis-
crete particles with an outer diameter of approximately 1 μm 
were found contained within the cytoplasm of THP-1 cells, 
as confirmed by merging of the bright-field channel. Coun-
ter-staining with DAPI confirmed the absence of intracel-
lular particulate material within cell nuclei (Fig. 2b). Native 
THP-1 cells stained with lumogallion in an identical manner 
revealed a weak brown/orange fluorescence emission that 
was clearly distinguishable against internalised lumogallion-
reactive particulates (see Supplementary Fig. 3).
Conventional morin staining of human brain tissue 
sections
Tissue sections of donors diagnosed with familial Alz-
heimer’s disease (fAD) were stained for the presence of 
aluminium using conventional Shaw’s morin staining. 
Therein, a positive green intracellular fluorescence emis-
sion was observed within astrocytic and neuronal-like cells 
in grey matter of the parietal lobe of a 47-year-old male 
(donor A1), diagnosed with early-onset fAD (Fig. 3a). 
Occasional intracellular accumulations of lipofuscin were 
also noted within neuronal-like cells via punctate deposits, 
highlighted via a yellow fluorescence emission (Fig. 3a). 
Tissue integrity of conventional Shaw’s morin-stained sec-
tions was found to be poor, in which damage appearing as 
tears and lost tissue was frequently observed.
Lumogallion staining of the adjacent section (Fig. 3b) 
revealed the presence of intracellular lipofuscin deposits 
that were identified via punctate yellow fluorescence, 
within neuronal-like cells. Interestingly, a positive 
(orange) fluorescence emission for lumogallion-reactive 
aluminium was not identified within adjacent serially 
sectioned cells, demonstrating the absence of the metal 
Fig. 1  Optimisation of morin 
staining for the detection of 
intracellular  Alhydrogel® in sec-
tioned THP-1 cells performed 
in the absence and presence of 
the autofluorescence quenching 
agent, Sudan Black B (SBB). a 
Native THP-1 cells stained with 
0.3% w/v SBB only (10 min), c 
0.2% w/v morin only (30 min) 
or e stained with morin and 
post-stained with SBB, respec-
tively. b, d and f THP-1 cells 
co-cultured with 50 μg/mL 
 Alhydrogel® and stained as with 
native THP-1 cells, respectively. 
All sections were mounted with 
ProLong Gold antifade reagent 
with DAPI and fluorescence 
micrographs depict morin stain-
ing (green) (U-MWBV2, long-
pass λem: 475 nm) with DAPI 
fluorescence (blue) (U-MWU2, 
longpass λem: 420 nm) overlaid. 
Magnified inserts are depicted 
with the bright-field channel 
merged in the lower panels. 
White arrows highlight distin-
guishable intracellular particu-
lates of the adjuvant. Scale bars: 
(a–d): 50 μm, (e, f): 20 μm
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ion (Fig. 3b). Therefore, these results identified false 
positives in utilising conventional Shaw’s morin stain-
ing for the identification of aluminium in human brain 
tissue.
Post‑staining with Sudan Black B (SBB) aids 
in the visualisation of aluminium in human brain 
tissue
In order to assess the efficacy of morin for the positive 
detection of aluminium in human brain tissue, optimised 
morin staining was performed in an identical manner to 
THP-1 cells post-stained with SBB. Staining of the fron-
tal and occipital cortex of a 60-year-old male donor (A5) 
diagnosed with familial Alzheimer’s disease (fAD) with 
0.3% w/v SBB only, produced an overall weak green 
fluorescence emission. Use of a modified morin filter set 
(longpass λem: 475 nm) revealed an occasional blue-green 
fluorescence emission noted within lipofuscin-like depos-
its in white (Fig. 4a) and grey (Fig. 4b) matter of the fron-
tal and occipital lobes, respectively.
Lumogallion staining of adjacent serial sections identified 
widespread lipofuscin deposition as identified via punctate 
yellow fluorescence concurrent with intracellular fluores-
cence in SBB only stained sections (Fig. 4c, d). Therein, a 
positive orange fluorescence emission indicative of lumogal-
lion-reactive aluminium was noted within senile plaque-like 
structures (Fig. 4c) and within cortical neurons (Fig. 4d). 
Fig. 2  Morin (green) and lumogallion (orange) fluorescence of 
THP-1 cells co-cultured with 50 μg/mL of an aluminium oxyhydrox-
ide-based  Alhydrogel® adjuvant. a Deparaffinised and rehydrated 
5 μm cell sections pre-treated with  Na2EDTA at 5 mM for 10 min, 
stained in 0.2% w/v morin in 85% v/v ethanol for 10 min and viewed 
under a U-MNIB3 (longpass λem: 510 nm) fluorescence filter cube. b 
Cell sections stained with 1 mM lumogallion for 45 min and viewed 
under a modified U-MNIB3 (single bandpass λem: 570–610 nm) fil-
ter cube. Sections were mounted with ProLong Gold antifade reagent 
with DAPI (Fisher Scientific, UK), highlighting the presence of cell 
nuclei via a blue fluorescence emission captured under a U-MWU2 
filter channel (longpass λem: 420 nm). Lower magnified inserts (aster-
isks) depict the merging of fluorescence with the bright-field channel. 
White arrows indicate the presence of intracellular particulates of the 
adjuvant. Scale bars: 20 μm
Fig. 3  Conventional Shaw’s morin and lumogallion staining of the 
parietal lobe of a donor (A1) diagnosed with familial Alzheimer’s 
disease (fAD). a Shaw’s morin staining of sectioned (5 μm) human 
brain tissue revealing a positive green fluorescence emission as 
viewed under a U-MWBV2 fluorescence filter channel (longpass λem: 
475 nm). b Lumogallion staining (U-MNIB3, longpass λem: 510 nm) 
of an adjacent serial section, demonstrating a lack of positive alumin-
ium staining (orange) in the same regions as those highlighted using 
morin fluorescence, as indicated by white arrows. Sections were 
mounted with the resinous mounting media Omnimount™ (National 
Diagnostics, UK). Magnified inserts are depicted (asterisks) of which 
the lower panels show fluorescence merged with the bright-field 
channel. Scale bars: 50 μm
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Optimised morin staining and SBB fluorescence quench-
ing of adjacent serial sections revealed positive green morin 
fluorescence, thereby indicating the presence of aluminium 
within identical regions of the frontal (Fig. 4e) and occipital 
(Fig. 4f) lobes, respectively.
In order to assess the efficacy of SBB in quenching lipo-
fuscin fluorescence of non-stained and lumogallion-stained 
tissue sections, a post-incubation step utilising SBB was intro-
duced. Autofluorescence of the parietal cortex of a 65-year-
old female donor (A8) diagnosed with fAD, revealed a dif-
fuse cortical senile-plaque approximately 25 μm in diameter, 
as highlighted via a green fluorescence emission (see Sup-
plementary Fig. 4a). Yellow punctate fluorescent pigments 
of lipofuscin were readily identified and their presence was 
also noted on lumogallion-stained sections (Supplementary 
Fig. 4b). Lumogallion staining of the identical senile plaque 
in a serial section revealed an orange fluorescence emission 
indicative of the presence of aluminium. Post-staining of 
adjacent lumogallion-stained sections with 0.01 and 0.10% 
w/v SBB quenched lipofuscin fluorescence, successfully 
masking its appearance (Supplementary Fig. 4c and d). At 
the highest SBB concentration of 0.10%, autofluorescence 
Fig. 4  Morin and lumogallion staining of adjacent serial sections 
from the frontal (a, c and e) and occipital (b, d and f) lobes of a donor 
(A5) diagnosed with familial Alzheimer’s disease (fAD). a, b 0.3% 
w/v Sudan Black B (SBB) staining (10 min), c, d 1 mM lumogallion 
staining (45 min) and e, f 0.2% w/v morin staining (30 min) followed 
by SBB autofluorescence quenching (10 min). Lumogallion (orange) 
(U-MNIB3, longpass λem: 510  nm) and morin fluorescence (green) 
(U-MWBV2, longpass λem: 475  nm) were identified in identical 
regions when prepared and stained as adjacent (5 μm) serial sections. 
Magnified inserts are highlighted (asterisks), of which the lower pan-
els show merging of the bright-field image with the respective morin 
(a, b, e and f) and lumogallion (c and d) fluorescence channels. Scale 
bars: 50 μm
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was near-abolished concomitant with reduced fluorescence 
intensity of positive lumogallion fluorescence.
Discussion
We have optimised the use of morin to allow for the unequiv-
ocal detection of aluminium in human cells and brain tissue. 
Owing to a bright excitation wavelength at approximately 
400 nm for mercury sources of illumination, a more intense 
fluorescence emission was observed for morin complexed 
to aluminium under an Olympus U-MWBV2 fluorescence 
filter cube (Mold et al. 2018a). Such acted as a simple means 
of increasing the fluorescence intensity of morin-stained 
human cells and tissue sections.
While morin reacts with aluminium to produce a fluores-
cent compound, it is also prone to false positives through 
non-preferential binding to physiologically relevant metal 
cations, including magnesium and calcium (Browne et al. 
1990). Furthermore, the green fluorescence emission 
(515 nm) of the fluorophore upon complexation to alumin-
ium (Browne et al. 1990) occurs at wavelengths similar to 
intrinsic autofluorescence produced upon excitation of non-
stained human cells and tissues (Mold et al. 2014; Mirza 
et al. 2017). Such spectral overlay hinders the identifica-
tion of a positive green fluorescence emission above a green 
autofluorescence background.
Such interferences have been overcome in the present 
study by post-incubating morin-stained cells and tissues 
with the fluorescence quenching agent Sudan Black B (SBB) 
(Table 1). SBB is a fat-soluble and hence, lysochrome-based, 
diazo dye that stains triglycerides and lipids in histological 
sections (Sun et al. 2011; Erben et al. 2016). Importantly, 
SBB is able to quench intrinsic autofluorescence of non-
stained specimens through its binding to intrinsically fluo-
rescent proteins and lipids, producing an opaque labelling 
(Schnell et al. 1999). Herein, the ability of SBB to absorb the 
energy released from intrinsically fluorescent tissue compo-
nents in the form of photons was exploited in an improved 
staining method for morin, with the overall effect of reduc-
ing autofluorescence (Schnell et al. 1999).
SBB prepared at 0.3% w/v in 70% ethanol was found opti-
mal for the post-quenching of autofluorescence in monocytic 
THP-1 cells co-cultured with an aluminium oxyhydroxide-
based vaccine adjuvant,  Alhydrogel®. Quenching of auto-
fluorescence was only necessary when using morin to detect 
intracellular particulates of the adjuvant versus the une-
quivocal detection offered by the fluorophore, lumogallion 
(Mold et al. 2014). Intracellular particulates of outer diam-
eter 0.97 ± 0.13 μm (mean ± SD, n = 30) were observed in 
THP-1 cells, in agreement with our previous studies of adju-
vant uptake in this cell line of 0.96 ± 0.19 μm (mean ± SD, 
n = 340) (Mold et al. 2016).
Alhydrogel® is the most commonly used aluminium-
based adjuvant (ABA) yet its inclusion in vaccines has been 
linked to the condition of macrophagic myofasciitis (MMF) 
in humans, forming granulomatous lesions (Gherardi and 
Authier 2012; Shardlow et al. 2018). Therefore, the une-
quivocal tracing of ABAs in biological systems is of criti-
cal importance in the design of safe and effective vaccines 
targeting disease. However, studies tracing the presence of 
 Alhydrogel® containing vaccines following their intramus-
cular administration in MMF, have continued to use morin in 
the absence of suitable autofluorescence controls (Chkheidze 
et al. 2017). These interferences could be easily overcome 
via the use of fluorescence quenching agents including SBB 
as optimised in this work. In a recent study highlighting 
morin as a sensitive and selective stain for the visualisation 
of aluminium in MMF tissues, such was substantiated by the 
use of the ligand, EDTA (Chkheidze et al. 2017). Therein, 
post-incubation of morin-stained sections with EDTA abol-
ished morin fluorescence.
While perhaps unsurprising that EDTA was capable of 
competitively chelating aluminium resulting in a reduction 
of the fluorescence intensity, this approach did not prove nor 
disprove that the fluorescence observed was as a result of 
interfering metal ions and or background autofluorescence 
(Chkheidze et al. 2017). Such may be further compounded 
when using positive fluorescence emission from morin-
stained cells to quantitatively assess migration of alumin-
ium into the central nervous system (Inohana et al. 2018). 
Therefore, experiments utilising morin for the detection of 
aluminium must ensure that background autofluorescence is 
suitably low or quenched and non-specific binding and false 
positives are accounted for.
Herein, we have adapted the use of EDTA as a pre-treat-
ment phase during staining which was found to increase 
the contrast of internalised ABA particulates, though not 
as effectively as post-staining with SBB. EDTA prefer-
entially binds to divalent metal ions and its use prior to 
staining would allow for interfering divalent metal ions to 
be chelated and removed, prior to staining for aluminium 
(Yokel 1994). It is of note, however, that EDTA coordi-
nates to aluminium and while its binding affinity is lower 
versus trivalent ion coordinators including desferrioxam-
ine, both ligands have been historically used to success-
fully chelate aluminium (Alfrey et al. 1976; Wills and 
Savory 1989; Yokel 1994). Overall, chelation using EDTA 
as a pre-treatment to staining would remove aluminium 
from the target tissues of interest resulting in the potential 
for false negatives when used with morin for the detection 
of aluminium.
SBB allowed for the unequivocal determination of alu-
minium using morin complemented with lumogallion 
staining, in human brain tissue of donors diagnosed with 
familial Alzheimer’s disease (fAD). This early-onset form of 
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Alzheimer’s disease is rare and mutations typically found in 
the amyloid precursor protein (APP) and presenilin (PSEN) 
genes exacerbate the formation of the neurotoxic and patho-
logically related peptide, amyloid-β42 (Goate et al. 1991; 
Sherrington et al. 1995; Pimplikar 2009). Subsequently, the 
peptide undergoes self-aggregation forming senile plaques 
that deposit in fAD tissues that are sinks for metal ions 
including aluminium and iron (Khan et al. 2006; Yumoto 
et al. 2009; Exley and House 2011; Mirza et al. 2017; Mujika 
et al. 2018). Therefore, direct fluorescent labels allowing for 
the unequivocal detection of aluminium in senile plaques 
and related neuropathological hallmarks of Alzheimer’s dis-
ease are of pertinent interest (Mirza et al. 2017).
Conventional Shaw’s morin staining damaged fAD donor 
tissue sections as a result of the HCl pre-rinse. Such was 
implemented in the original protocol to prevent interferences 
in the binding of calcium and magnesium to morin (Shaw and 
Petrik 2009). Furthermore, positive intracellular fluorescence 
indicating the presence of aluminium in glial and non-neu-
ronal cells in morin-stained sections herein was not detectable 
upon adjacent lumogallion-stained sections. This highlighted 
false positives in the use of Shaw’s morin staining in identi-
fying aluminium in human brain tissue. Tissue sections of 
fAD donors additionally revealed lipofuscin in both stained 
and non-stained sections. Lipofuscin is an ageing-associated 
pigment that accumulates in neurones and fluoresces across 
a broad spectral range (Schnell et al. 1999). SBB has been 
shown to be effective in quenching lipofuscin fluorescence 
in even the thickest (250–350 μm) of human spinal cord and 
brain tissue sections in a procedure called Brain Lipids and 
Aldehyde Quench (BLAQ) (Kupferschmidt et al. 2015).
Herein, SBB successfully quenched lipofuscin and back-
ground autofluorescence allowing for a marked improvement 
in the identification of positive morin fluorescence. This was 
made possible through improvements to the signal-to-noise 
ratio of the fluorophore. Use of this optimised protocol 
removed the need for pre-treatment measures to remove inter-
fering metal ions with the additional benefit of omitting the use 
of glacial acetic acid from morin staining solutions (Shaw and 
Petrik 2009). The latter increases the acidity of the morin stain-
ing solution increasing the likelihood of aluminium leaching 
from stained tissues in the form of Al3+
(aq)
 (Exley 1996; Mold 
et al. 2014). Importantly, lumogallion was capable of unequiv-
ocally identifying aluminium in human cells and tissues with-
out the need for additional pre-treatment steps nor post-stain-
ing with SBB. Use of this improved method for morin allowed 
for intracellular aluminium to be detected in cortical neurons 
and extracellular aluminium to be detected in senile plaques in 
human brain tissue of donors diagnosed with fAD, as has now 
been demonstrated with lumogallion in a number of recent 
studies (Mirza et al. 2017; Mold et al. 2014, 2016, 2018a, b, c, 
2019a, b). In summary, we have developed a both simplified 
and optimised morin staining protocol that allowed for the 
unequivocal detection of aluminium in both human cells and 
brain tissue. These methods are immediately applicable to the 
use of both new and existing fluorophores for the unequivocal 
detection of aluminium in vivo.
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